Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer

References

• zur Hausen H. Papillomaviruses--to vaccination and beyond. Biochemistry (Mosc) 2008; 73:498 - 503; http://dx.doi.org/10.1134/S0006297908050027; PMID: 18605974
   PubMed Web of Science ®Google Scholar
• Hesson LB, Cooper WN, Latif F. Evaluation of the 3p21.3 tumour-suppressor gene cluster. Oncogene 2007; 26:7283 - 301; http://dx.doi.org/10.1038/sj.onc.1210547; PMID: 17533367
   PubMed Web of Science ®Google Scholar
• Ji L, Minna JD, Roth JA. 3p21.3 tumor suppressor cluster: prospects for translational applications. Future Oncol 2005; 1:79 - 92; http://dx.doi.org/10.1517/14796694.1.1.79; PMID: 16555978
   PubMedGoogle Scholar
• Senchenko V, Liu J, Braga E, Mazurenko N, Loginov W, Seryogin Y, et al. Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas. Oncogene 2003; 22:2984 - 92; http://dx.doi.org/10.1038/sj.onc.1206429; PMID: 12771950
   PubMed Web of Science ®Google Scholar
• Senchenko VN, Liu J, Loginov W, Bazov I, Angeloni D, Seryogin Y, et al. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene 2004; 23:5719 - 28; http://dx.doi.org/10.1038/sj.onc.1207760; PMID: 15208675
   PubMed Web of Science ®Google Scholar
• Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 2010; 31:27 - 36; http://dx.doi.org/10.1093/carcin/bgp220; PMID: 19752007
   PubMed Web of Science ®Google Scholar
• Dmitriev AA, Kashuba VI, Haraldson K, Senchenko VN, Pavlova TV, Kudryavtseva AV, et al. Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays. Epigenetics 2012; 7:502 - 13; http://dx.doi.org/10.4161/epi.19801; PMID: 22491060
   PubMed Web of Science ®Google Scholar
• Kashuba V, Dmitriev AA, Krasnov GS, Pavlova T, Ignatjev I, Gordiyuk VV, et al. NotI Microarrays: Novel Epigenetic Markers for Early Detection and Prognosis of High Grade Serous Ovarian Cancer. Int J Mol Sci 2012; 13:13352 - 77; http://dx.doi.org/10.3390/ijms131013352; PMID: 23202957
   PubMed Web of Science ®Google Scholar
• Gerashchenko GV, Gordiyuk VV, Skrypkina IY, Kvasha SM, Kolesnik OO, Ugryn DD, et al. Screening of epigenetic and genetic disturbances of human chromosome 3 genes in colorectal cancer. Ukr Biokhim Zh 2009; 81:81 - 7; PMID: 20387637
   PubMedGoogle Scholar
• Li J, Protopopov A, Wang F, Senchenko V, Petushkov V, Vorontsova O, et al. NotI subtraction and NotI-specific microarrays to detect copy number and methylation changes in whole genomes. Proc Natl Acad Sci U S A 2002; 99:10724 - 9; http://dx.doi.org/10.1073/pnas.132271699; PMID: 12149436
   PubMed Web of Science ®Google Scholar
• Zabarovsky ER, Boldog F, Thompson T, Scanlon D, Winberg G, Marcsek Z, et al. Construction of a human chromosome 3 specific NotI linking library using a novel cloning procedure. Nucleic Acids Res 1990; 18:6319 - 24; http://dx.doi.org/10.1093/nar/18.21.6319; PMID: 2243778
   PubMed Web of Science ®Google Scholar
• Kashuba VI, Gizatullin RZ, Protopopov AI, Li J, Vorobieva NV, Fedorova L, et al. Analysis of NotI linking clones isolated from human chromosome 3 specific libraries. Gene 1999; 239:259 - 71; http://dx.doi.org/10.1016/S0378-1119(99)00411-4; PMID: 10548727
   PubMed Web of Science ®Google Scholar
• Gerashchenko GV, Bogatyrova OO, Rudenko EE, Kondratov AG, Gordiyuk VV, Zgonnyk YM, et al. Genetic and epigenetic changes of NKIRAS1 gene in human renal cell carcinomas. Exp Oncol 2010; 32:71 - 5; PMID: 20693965
   PubMedGoogle Scholar
• Senchenko VN, Anedchenko EA, Kondratieva TT, Krasnov GS, Dmitriev AA, Zabarovska VI, et al. Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer. BMC Cancer 2010; 10:75; http://dx.doi.org/10.1186/1471-2407-10-75; PMID: 20193080
   PubMed Web of Science ®Google Scholar
• Dammann R, Schagdarsurengin U, Seidel C, Strunnikova M, Rastetter M, Baier K, et al. The tumor suppressor RASSF1A in human carcinogenesis: an update. Histol Histopathol 2005; 20:645 - 63; PMID: 15736067
   PubMed Web of Science ®Google Scholar
• Kuzmin I, Liu L, Dammann R, Geil L, Stanbridge EJ, Wilczynski SP, et al. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Cancer Res 2003; 63:1888 - 93; PMID: 12702579
   PubMed Web of Science ®Google Scholar
• Seoud M, Tjalma WA, Ronsse V. Cervical adenocarcinoma: moving towards better prevention. Vaccine 2011; 29:9148 - 58; http://dx.doi.org/10.1016/j.vaccine.2011.09.115; PMID: 21983356
   PubMed Web of Science ®Google Scholar
• Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999; 96:8681 - 6; http://dx.doi.org/10.1073/pnas.96.15.8681; PMID: 10411935
   PubMed Web of Science ®Google Scholar
• Lendvai A, Johannes F, Grimm C, Eijsink JJ, Wardenaar R, Volders HH, et al. Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia. Epigenetics 2012; 7:1268 - 78; http://dx.doi.org/10.4161/epi.22301; PMID: 23018867
   PubMed Web of Science ®Google Scholar
• Overmeer RM, Louwers JA, Meijer CJ, van Kemenade FJ, Hesselink AT, Daalmeijer NF, et al. Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women. Int J Cancer 2011; 129:2218 - 25; http://dx.doi.org/10.1002/ijc.25890; PMID: 21190187
   PubMed Web of Science ®Google Scholar
• Reesink-Peters N, Wisman GB, Jéronimo C, Tokumaru CY, Cohen Y, Dong SM, et al. Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study. Mol Cancer Res 2004; 2:289 - 95; PMID: 15192122
   PubMed Web of Science ®Google Scholar
• Widschwendter A, Gattringer C, Ivarsson L, Fiegl H, Schneitter A, Ramoni A, et al. Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors. Clin Cancer Res 2004; 10:3396 - 400; http://dx.doi.org/10.1158/1078-0432.CCR-03-0143; PMID: 15161694
   PubMed Web of Science ®Google Scholar
• Anedchenko EA, Kiseleva NP, Dmitriev AA, Kiselev FL, Zabarovskiĭ ER, Senchenko VN. [Tumor suppressor gene RBSP3 in cervical carcinoma: copy number and transcriptional level]. Mol Biol (Mosk) 2007; 41:86 - 95; http://dx.doi.org/10.1134/S0026893307010116; PMID: 17380895
   PubMed Web of Science ®Google Scholar
• Mitra S, Mazumder Indra D, Bhattacharya N, Singh RK, Basu PS, Mondal RK, et al. RBSP3 is frequently altered in premalignant cervical lesions: clinical and prognostic significance. Genes Chromosomes Cancer 2010; 49:155 - 70; PMID: 19885927
   PubMed Web of Science ®Google Scholar
• Protopopov A, Kashuba V, Zabarovska VI, Muravenko OV, Lerman MI, Klein G, et al. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies. Cancer Res 2003; 63:404 - 12; PMID: 12543795
   PubMed Web of Science ®Google Scholar
• Leris AC, Roberts TR, Jiang WG, Newbold RF, Mokbel K. Evidence for a tumour suppressive function of APRG1 in breast cancer. Breast Cancer Res Treat 2005; 93:97 - 100; http://dx.doi.org/10.1007/s10549-005-4169-z; PMID: 16187228
   PubMed Web of Science ®Google Scholar
• Mahajan-Miklos S, Cooley L. The villin-like protein encoded by the Drosophila quail gene is required for actin bundle assembly during oogenesis. Cell 1994; 78:291 - 301; http://dx.doi.org/10.1016/0092-8674(94)90298-4; PMID: 8044841
   PubMed Web of Science ®Google Scholar
• Zhang MQ, Lin F, Hui P, Chen ZM, Ritter JH, Wang HL. Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma. Am J Clin Pathol 2007; 128:808 - 16; http://dx.doi.org/10.1309/JAF3KVGJHQCJ1QF9; PMID: 17951204
   PubMed Web of Science ®Google Scholar
• Kennedy MT, Jordan RC, Berean KW, Perez-Ordoñez B. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. J Clin Pathol 2004; 57:932 - 7; http://dx.doi.org/10.1136/jcp.2004.016964; PMID: 15333652
   PubMed Web of Science ®Google Scholar
• Anedchenko EA, Dmitriev AA, Krasnov GS, Kondrat’eva TT, Kopantsev EP, Vinogradova TV, et al. [Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer]. Mol Biol (Mosk) 2008; 42:965 - 76; http://dx.doi.org/10.1134/S0026893308060058; PMID: 19140316
   PubMed Web of Science ®Google Scholar
• Tsang JS, Ebert MS, van Oudenaarden A. Genome-wide dissection of microRNA functions and cotargeting networks using gene set signatures. Mol Cell 2010; 38:140 - 53; http://dx.doi.org/10.1016/j.molcel.2010.03.007; PMID: 20385095
   PubMed Web of Science ®Google Scholar
• Weber F, Teresi RE, Broelsch CE, Frilling A, Eng C. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. J Clin Endocrinol Metab 2006; 91:3584 - 91; http://dx.doi.org/10.1210/jc.2006-0693; PMID: 16822819
   PubMed Web of Science ®Google Scholar
• Selth LA, Townley S, Gillis JL, Ochnik AM, Murti K, Macfarlane RJ, et al. Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease. Int J Cancer 2012; 131:652 - 61; http://dx.doi.org/10.1002/ijc.26405; PMID: 22052531
   PubMed Web of Science ®Google Scholar
• Scapoli L, Palmieri A, Lo Muzio L, Pezzetti F, Rubini C, Girardi A, et al. MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int J Immunopathol Pharmacol 2010; 23:1229 - 34; PMID: 21244772
   PubMed Web of Science ®Google Scholar
• Frigola J, Song J, Stirzaker C, Hinshelwood RA, Peinado MA, Clark SJ. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat Genet 2006; 38:540 - 9; http://dx.doi.org/10.1038/ng1781; PMID: 16642018
   PubMed Web of Science ®Google Scholar
• Coolen MW, Stirzaker C, Song JZ, Statham AL, Kassir Z, Moreno CS, et al. Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity. Nat Cell Biol 2010; 12:235 - 46; PMID: 20173741
   PubMed Web of Science ®Google Scholar
• Dunwell TL, Hesson LB, Pavlova T, Zabarovska V, Kashuba V, Catchpoole D, et al. Epigenetic analysis of childhood acute lymphoblastic leukemia. Epigenetics 2009; 4:185 - 93; http://dx.doi.org/10.4161/epi.4.3.8752; PMID: 19430199
   PubMed Web of Science ®Google Scholar
• Krasnov GS, Oparina NIu, Dmitriev AA, Kudriavtsev AV, Anedchenko EA, Kondrat’eva TT, et al. [Novel reference gene RPN1 for normalization of quantitative data in lung and kidney cancer]. Mol Biol (Mosk) 2011; 45:238 - 48; http://dx.doi.org/10.1134/S0026893311020129; PMID: 21634111
   PubMed Web of Science ®Google Scholar
• Senchenko VN, Krasnov GS, Dmitriev AA, Kudryavtseva AV, Anedchenko EA, Braga EA, et al. Differential expression of CHL1 gene during development of major human cancers. PLoS One 2011; 6:e15612; http://dx.doi.org/10.1371/journal.pone.0015612; PMID: 21408220
   PubMed Web of Science ®Google Scholar
• Glantz SA. Primer of biostatistics. New York, USA: McGRAW-HILL, 2005.
   Google Scholar
• Altman DG, Bland JM. Diagnostic tests. 1: Sensitivity and specificity. BMJ 1994; 308:1552; http://dx.doi.org/10.1136/bmj.308.6943.1552; PMID: 8019315
   PubMed Web of Science ®Google Scholar